Early use of TLV | Delayed use of TLV | P value | |
---|---|---|---|
(n = 40) | (n = 61) | ||
Body mass index (kg/m2) | 19.4 ± 2.9 | 19.7 ± 4.2 | 0.603 |
NYHA class (II/III/IV) | 0/55/6 | 1/33/6 | 0.705 |
CS class (I/II/III) | 19/38/4 | 6/28/6 | 0.026 |
Systolic BP (mm Hg) on admission | 130.8 ± 22.7 | 121.5 ± 19.9 | 0.037 |
Diastolic BP (mm Hg) on admission | 70.3 ± 13.8 | 64.1 ± 11.5 | 0.020 |
Heart rate (bpm) | 82.5 ± 20.5 | 85.5 ± 23.7 | 0.506 |
AST (IU/L) | 34.0 ± 22.8 | 40.9 ± 47.0 | 0.329 |
ALT (IU/L) | 24.1 ± 18.2 | 31.5 ± 53.4 | 0.323 |
eGFR (ml/min/1.73 m2) | 43.8 ± 19.4 | 40.5 ± 22.8 | 0.431 |
Hemoglobin (g/dL) | 11.4 ± 1.9 | 11.0 ± 2.1 | 0.326 |
Brain natriuretic peptide (pg/mL) | 1502.2 ± 211.9 | 850.2 ± 96.8 | 0.019 |
Ejection fraction (%) | 51.0 ± 18.1 | 55.1 ± 18.5 | 0.268 |
HFpEF (n, %) | 30, 49.2 | 23, 57.5 | 0.418 |
Length of hospital stay | 21.3 ± 12.5 | 32.9 ± 17.9 | < 0.001 |
Time until commencement of TLV from hospitalization | 3.0 ± 1.3 | 13.6 ± 11.6 | < 0.001 |
Length of hospital stay after initiation of TLV | 18.3 ± 12.4 | 19.3 ± 12.7 | 0.699 |